SUEZ financials
SUEZ
Country: FR Reporting currency: EUR Latest annual report: 2020-12-31
LEI:
549300JQIZM6CL7POC81 Financial statements
(EUR, as reported — unscaled; 123 line items across 2 annual periods)
| Line item | 2020 | 2019 |
|---|---|---|
| Income statement | ||
| Revenue | €17.21B | €18.02B |
| Employee benefits expense | €4.70B | €4.70B |
| Raw materials & consumables used | €3.44B | €3.72B |
| Depreciation & amortisation | €1.76B | €1.53B |
| Operating profit (EBIT) | €375.9M | €1.26B |
| Net finance income / (cost) | -€440.7M | -€514.0M |
| Finance costs | €523.2M | €603.8M |
| Income tax expense | €154.4M | €340.0M |
| Profit for the year | -€74.4M | €609.2M |
| — attributable to owners | -€228.2M | €351.7M |
| — attributable to NCI | €153.8M | €257.5M |
| Total comprehensive income | -€613.1M | €481.1M |
| Per share | ||
| Basic EPS | €-0.43 | €0.49 |
| Diluted EPS | €-0.43 | €0.48 |
| Cash flow statement | ||
| Cash generated from operations | €2.09B | €2.86B |
| Net cash from operating activities | €2.12B | €2.45B |
| Income taxes paid | €174.9M | €253.3M |
| Net cash from investing activities | -€875.5M | -€1.45B |
| Net cash from financing activities | €424.0M | -€860.7M |
| Dividends paid | €433.0M | €661.5M |
| Proceeds from borrowings | €2.44B | €1.40B |
| Repayments of borrowings | €867.9M | €1.45B |
| Lease liability payments | €331.5M | €325.1M |
| Balance sheet | ||
| Total assets | €35.58B | €35.63B |
| Non-current assets | €21.68B | €24.15B |
| Property, plant & equipment | €7.76B | €8.89B |
| Right-of-use assets | €1.17B | €1.41B |
| Intangible assets & goodwill | €4.66B | €5.32B |
| Current assets | €12.46B | €11.48B |
| Inventories | €483.1M | €528.0M |
| Trade & other receivables | €4.32B | €4.67B |
| Cash & equivalents | €5.32B | €3.70B |
| Total equity | €8.05B | €9.23B |
| — attributable to owners | €5.41B | €6.41B |
| Non-controlling interests | €2.64B | €2.82B |
| Non-current liabilities | €14.74B | €14.25B |
| Long-term borrowings | €10.99B | €9.91B |
| Lease liabilities (non-current) | €975.5M | €1.16B |
| Current liabilities | €12.21B | €12.15B |
| Short-term borrowings | €2.96B | €2.61B |
| Lease liabilities (current) | €255.6M | €314.9M |
| Trade & other payables | €3.26B | €3.53B |
| Deferred tax liabilities | €596.2M | €791.1M |
| Derived metrics | ||
| Operating margin | 2.2% | 7.0% |
| Net margin | -0.4% | 3.4% |
| Return on equity | -0.9% | 6.6% |
| Cash conversion ratio | -28.45× | 4.02× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €1.74B | €1.47B |
| Adjustments For Dividend Income | -€121.4M | -€131.8M |
| Adjustments For Finance Income Cost | -€440.7M | -€514.0M |
| Adjustments For Income Tax Expense | €154.4M | €340.0M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€156.3M | -€36.6M |
| Bank Overdrafts Classified As Cash Equivalents | €902.1M | €837.1M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €4.42B | €2.87B |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €295.4M | €27.6M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€13.7M | €49.6M |
| Current Contract Assets | €498.4M | €733.8M |
| Current Contract Liabilities | €1.18B | €911.3M |
| Current Derivative Financial Assets | €96.4M | €75.5M |
| Current Derivative Financial Liabilities | €36.2M | €57.3M |
| Current Financial Assets At Amortised Cost | €77.0M | €91.4M |
| Current Financial Assets At Fair Value Through Profit Or Loss | €54.9M | €29.8M |
| Current Provisions | €541.8M | €475.2M |
| Deferred Tax Assets | €432.4M | €541.9M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €325.0M | €448.8M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €195.1M | €266.8M |
| Dividends Received Classified As Investing Activities | €3.0M | €3.6M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€113.7M | €20.6M |
| Equity and Liabilities | €35.58B | €35.63B |
| Expense of Restructuring Activities | €157.0M | €132.3M |
| Finance Income | €82.5M | €89.8M |
| Gains Losses On Change In Fair Value of Derivatives | €4.6M | €3.7M |
| Gains Losses On Disposals of Noncurrent Assets | -€50.6M | €26.6M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €209.2M | €64.8M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -€5.1M | €2.3M |
| Income Tax Relating To Investments In Equity Instruments of Other Comprehensive Income | €100.0K | €100.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€13.1M | €16.0M |
| Increase Decrease In Cash and Cash Equivalents | €1.55B | €155.7M |
| Increase Decrease In Working Capital | -€202.0M | €153.1M |
| Increase Decrease Through Change In Equity of Subsidiaries | €12.5M | — |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€700.0K | €501.1M |
| Increase Decrease Through Sharebased Payment Transactions | €1.9M | €17.5M |
| Increase Decrease Through Transfers and Other Changes Equity | -€75.9M | -€200.0K |
| Increase Decrease Through Treasury Share Transactions | €700.0K | €2.9M |
| Intangible Assets Other Than Goodwill | €4.46B | €4.84B |
| Investments In Associates Accounted For Using Equity Method | €1.06B | €1.07B |
| Investments In Joint Ventures Accounted For Using Equity Method | €925.5M | €953.9M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €586.4M | €0 |
| Miscellaneous Other Operating Expense | €6.91B | €7.09B |
| Miscellaneous Other Operating Income | €236.4M | €236.7M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €1.44B | €0 |
| Noncurrent Contract Assets | €80.6M | €46.2M |
| Noncurrent Contract Liabilities | €196.3M | €267.3M |
| Noncurrent Derivative Financial Assets | €146.5M | €115.7M |
| Noncurrent Derivative Financial Liabilities | €4.9M | €6.7M |
| Noncurrent Financial Assets At Amortised Cost | €712.2M | €653.7M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €107.9M | €132.2M |
| Noncurrent Provisions | €1.41B | €1.50B |
| Number of Shares Outstanding | 628.4M | 621.4M |
| Other Adjustments For Noncash Items | €700.0K | €17.8M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €7.8M | €15.9M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €400.0K | €8.7M |
| Other Comprehensive Income | -€538.7M | -€128.1M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -€501.7M | — |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | -€3.5M | €6.3M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€33.2M | -€90.6M |
| Other Comprehensive Income Before Tax Hedges of Net Investments In Foreign Operations | €1.2M | €0 |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€501.7M | -€15.6M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€515.0M | -€27.7M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€23.7M | -€100.4M |
| Other Current Assets | €1.61B | €1.65B |
| Other Current Liabilities | €3.98B | €4.25B |
| Other Noncurrent Assets | €159.7M | €184.8M |
| Other Noncurrent Financial Liabilities | €37.6M | €42.8M |
| Other Noncurrent Liabilities | €524.1M | €566.6M |
| Proceeds From Contributions of Noncontrolling Interests | €10.4M | €5.2M |
| Proceeds From Issuing Shares | €112.2M | €0 |
| Proceeds From Sales of Investments Accounted For Using Equity Method | €63.1M | €15.8M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €61.9M | €23.1M |
| Reduction of Issued Capital | €0 | — |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €105.1M | €126.9M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €144.8M | €198.3M |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | €39.7M | €71.4M |
Methodology
Every line item above is a fact tagged in SUEZ's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.